Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome.

Corsetti JP, Zareba W, Moss AJ, Sparks CE.

Atherosclerosis. 2004 Dec;177(2):367-73.


Lp(a) and risk of recurrent cardiac events in obese postinfarction patients.

Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE.

Obesity (Silver Spring). 2008 Dec;16(12):2717-22. doi: 10.1038/oby.2008.441. Epub 2008 Oct 16.


High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients.

Corsetti JP, Rainwater DL, Moss AJ, Zareba W, Sparks CE.

Clin Chem. 2006 Jul;52(7):1331-8. Epub 2006 May 18.


Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans.

Enkhmaa B, Anuurad E, Zhang Z, Pearson TA, Berglund L.

Am J Cardiol. 2010 Nov 1;106(9):1264-9. doi: 10.1016/j.amjcard.2010.06.056.


The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.

Lind L, Vessby B, Sundström J.

Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):406-10. Epub 2005 Nov 23.


Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus.

Mehta NN, Krishnamoorthy P, Martin SS, St Clair C, Schwartz S, Iqbal N, Braunstein S, Schutta M, Rader DJ, Reilly MP.

Am J Cardiol. 2011 Feb 1;107(3):406-11. doi: 10.1016/j.amjcard.2010.09.035.


Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.

Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F.

Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6.


VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.

Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E.

Circulation. 2000 Oct 17;102(16):1886-92.


Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators.

Kalaria VG, Zareba W, Moss AJ, Pancio G, Marder VJ, Morrissey JH, Weiss HJ, Sparks CE, Greenberg H, Dwyer E, Goldstein R, Watelet LF.

Am J Cardiol. 2000 Jun 15;85(12):1401-8.


Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.


Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents.

Won KB, Kim BK, Chang HJ, Shin DH, Kim JS, Ko YG, Choi D, Ha JW, Hong MK, Jang Y.

Catheter Cardiovasc Interv. 2014 Apr 1;83(5):713-20. doi: 10.1002/ccd.25150. Epub 2013 Nov 15.


Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.

Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators.

Cardiovasc Diabetol. 2011 Nov 21;10:102. doi: 10.1186/1475-2840-10-102.


Thrombogenic factors and recurrent coronary events.

Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM Jr, Arora R, Marcus FI, Watelet LF, Case RB.

Circulation. 1999 May 18;99(19):2517-22.


Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.

Selcuk H, Temizhan A, Selcuk MT, Sen T, Maden O, Tekeli S, Sasmaz A.

Coron Artery Dis. 2009 Sep;20(6):370-5. doi: 10.1097/MCA.0b013e32832ed31e.


ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.

Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellénius ML, Fisher RM.

Eur Heart J. 2007 Nov;28(21):2637-43. Epub 2007 Sep 1.


Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes.

Birhan Yilmaz M, Guray U, Guray Y, Altay H, Demirkan B, Caldir V, Cay S, Refiker ME, Sasmaz H, Korkmaz S.

Coron Artery Dis. 2005 Aug;16(5):287-92.


Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients.

Corsetti JP, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rainwater DL, Sparks CE.

Atherosclerosis. 2003 Dec;171(2):351-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk